Study guide
10.2 Acquisition Analysis & Business Combination Valuation Entries
CPA Program — Financial Reporting Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The Reporting Environment & Conceptual Framework
1.1 General Purpose Financial Reporting & The International Environment 1.2 Qualitative Characteristics & Elements of Financial Statements 1.3 Recognition, Derecognition & Measurement Bases
2 Chapter 2: Measurement Applications & Professional Judgement
2.1 Measurement Applications Across IFRS Standards 2.2 Materiality & Professional Judgement in Reporting 2.3 Exam Strategy & The CPA Financial Reporting Open-Book Architecture
3 Chapter 3: Primary Financial Statements & IAS 1 Presentation
3.1 IAS 1 Presentation Foundations & Statement of Financial Position 3.2 Statement of Profit or Loss and Other Comprehensive Income 3.3 Statement of Changes in Equity & Note Disclosures 3.4 IAS 7 Statement of Cash Flows
4 Chapter 4: Accounting Policies, Estimates, Post-Balance Date Events & Segments
4.1 IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors 4.2 IAS 10 Events After the Reporting Period 4.3 IFRS 8 Operating Segments & IAS 34 Interim Financial Reporting
5 Chapter 5: IFRS 15 Revenue from Contracts with Customers
5.1 The Five-Step Revenue Model: Steps 1 to 3 5.2 The Five-Step Revenue Model: Steps 4 & 5 5.3 Specific IFRS 15 Applications, Contract Costs & Disclosures
6 Chapter 6: IAS 37 Provisions, Contingent Liabilities & Contingent Assets
6.1 Provisions Recognition Criteria & Measurement 6.2 Specific Provision Applications 6.3 Contingent Liabilities & Contingent Assets
7 Chapter 7: Fundamentals of Income Taxes & Temporary Differences
7.1 IAS 12 Balance Sheet Liability Method & Current Tax 7.2 Tax Bases of Assets & Liabilities 7.3 Taxable Temporary Differences & Deferred Tax Liabilities 7.4 Deductible Temporary Differences & Deferred Tax Assets
8 Chapter 8: Deferred Tax Advanced Applications, Revaluations & Disclosures
8.1 Initial Recognition Exemption & Recent Amendments 8.2 Deferred Tax on Revalued Assets & OCI/Equity Items 8.3 Measurement Principles & Strict Prohibition on Discounting 8.4 Financial Statement Presentation, Disclosures & Tax Reconciliation
9 Chapter 9: IFRS 3 Business Combinations & The Acquisition Method
9.1 Scope of IFRS 3 & Identifying a Business Combination 9.2 Acquisition Date & Consideration Transferred 9.3 Recognising & Measuring Identifiable Net Assets & NCI 9.4 Goodwill & Gain on Bargain Purchase
10 Chapter 10: IFRS 10 Consolidation Principles & Elimination Mechanics
10.1 IFRS 10 Control Model & Consolidation Procedures 10.2 Acquisition Analysis & Business Combination Valuation Entries 10.3 Intragroup Balances & Transactions Elimination 10.4 Unrealised Profits in Intragroup Asset Transfers
11 Chapter 11: Associates, Joint Arrangements & Group Disclosures
11.1 IAS 28 Investments in Associates & The Equity Method 11.2 IFRS 11 Joint Arrangements 11.3 Group Reporting Disclosures & Changes in Ownership
12 Chapter 12: Classification, Measurement & Impairment of Financial Instruments
12.1 Financial Instrument Definitions & Scope 12.2 Classification & Measurement of Financial Assets 12.3 Classification & Measurement of Financial Liabilities & Derecognition 12.4 Impairment: The Expected Credit Loss (ECL) Model
13 Chapter 13: Presentation, Compound Instruments & Hedge Accounting
13.1 IAS 32 Presentation: Debt vs Equity Classification 13.2 Compound Financial Instruments & Split Accounting 13.3 IFRS 9 Hedge Accounting & IFRS 7 Risk Disclosures
14 Chapter 14: IAS 36 Foundations & Impairment of Individual Assets
14.1 Scope of IAS 36 & Indicators of Impairment 14.2 Recoverable Amount: FVLCD vs Value in Use 14.3 Impairment Testing & Accounting for Individual Assets
15 Chapter 15: Cash-Generating Units, Goodwill & Impairment Reversals
15.1 Identification & Impairment of Cash-Generating Units (CGUs) 15.2 Goodwill Impairment & Allocation of Losses 15.3 Impairment Reversals & Mandatory Annual Testing
10.2 Acquisition Analysis & Business Combination Valuation Entries
Key Takeaways Explain This Topic AI
The acquisition analysis compares the consideration transferred (plus NCI) against the fair value of identifiable net assets acquired, establishing Goodwill or a Gain on Bargain Purchase at the acquisition date.
Business Combination Valuation (BCV) consolidation entries adjust the subsidiary's identifiable assets and liabilities from book value to fair value, recognizing deferred tax liabilities or assets under IAS 12 for the resulting temporary differences.
The pre-acquisition equity elimination entry eliminates the parent's investment asset against the subsidiary's acquisition-date share capital, retained earnings, reserves, and after-tax BCV reserve while recognizing initial NCI.
In post-acquisition periods, fair value adjustments must be amortized or depreciated through consolidated profit or loss (e.g., additional plant depreciation or sale of undervalued inventory), accompanied by deferred tax reversals.
In later years, prior-period BCV depreciation adjustments go to opening retained earnings, and NCI is credited with its share of the subsidiary's adjusted post-acquisition profit and retained earnings, less its share of dividends.
Last updated: October 2026
10.2 Acquisition Analysis & Business Combination Valuation Entries
Core Principle: At the date of acquisition, the parent must prepare an acquisition analysis comparing purchase consideration with the fair value of identifiable net assets acquired. In the consolidation worksheet, Business Combination Valuation (BCV) entries restate the subsidiary's identifiable assets and liabilities to fair value net of deferred tax under IAS 12, after which pre-acquisition equity is eliminated against the parent's investment.
Consolidation does not alter the standalone accounting records of the legal parent or legal subsidiary. Instead, consolidation entries exist solely on the consolidation worksheet to produce group financial statements. When a parent acquires a subsidiary, the subsidiary's assets and liabilities are recorded in its own ledger at historical carrying amounts. To present the group as a single entity, the consolidation worksheet must bring those assets and liabilities to fair value at acquisition date and eliminate the reciprocal investment and equity balances.
The Acquisition Analysis Architecture
The acquisition analysis is a technical calculation performed at the acquisition date to determine:
- The carrying amount of the subsidiary's equity at acquisition;
- The fair value adjustments required to restate identifiable assets and liabilities;
- The deferred tax consequences under IAS 12; and
The resulting Goodwill or Gain on Bargain Purchase. Book Value of Subsidiary Equity = Share Capital + Retained Earnings + Reserves (at acquisition date) Identifiable Net Assets at FV = Book Value of Equity + ∑ [ Pre-Tax FV Adjustments × ( 1 − t ) ] Goodwill = Consideration Transferred + NCI − Identifiable Net Assets at FV \begin{aligned}
\text{Book Value of Subsidiary Equity} &= \text{Share Capital} + \text{Retained Earnings} + \text{Reserves (at acquisition date)} \\[6pt]
\text{Identifiable Net Assets at FV} &= \text{Book Value of Equity} + \sum \left[ \text{Pre-Tax FV Adjustments} \times (1 - t) \right] \\[6pt]
\text{Goodwill} &= \text{Consideration Transferred} + \text{NCI} - \text{Identifiable Net Assets at FV}
\end{aligned} Book Value of Subsidiary Equity Identifiable Net Assets at FV Goodwill = Share Capital + Retained Earnings + Reserves (at acquisition date) = Book Value of Equity + ∑ [ Pre-Tax FV Adjustments × ( 1 − t ) ] = Consideration Transferred + NCI − Identifiable Net Assets at FV
Where t t t represents the applicable statutory corporate tax rate (e.g., 30% in Australia).
Business Combination Valuation (BCV) Entries & Deferred Tax
Under IFRS 3.18, the acquirer must measure all identifiable assets acquired and liabilities assumed at their acquisition-date fair values . Under IAS 12 Income Taxes , adjusting an asset or liability to fair value for consolidation purposes changes its carrying amount in the consolidated financial statements without altering its tax base (which remains governed by historical tax records). This divergence creates a temporary difference that mandates the recognition of deferred tax.
Typical BCV Adjustments and Tax Treatments
Acquired Asset / Liability Nature of FV Adjustment Tax Temporary Difference BCV Consolidation Worksheet Entry
Land (Non-Depreciable) Upward revaluation Taxable temporary difference ( C A > T B CA > TB C A > TB ) Dr Land; Cr Deferred Tax Liability ( F V step-up × t FV \text{ step-up} \times t F V step-up × t ); Cr BCV Reserve (net after-tax step-up)
Plant & Equipment Fair value exceeds carrying amount Taxable temporary difference ( C A > T B CA > TB C A > TB ) Dr Plant & Equipment (gross FV step-up); Cr Deferred Tax Liability ( s t e p − u p × t step-up \times t s t e p − u p × t ); Cr BCV Reserve (after-tax step-up)
Inventory Fair value exceeds carrying amount Taxable temporary difference ( C A > T B CA > TB C A > TB ) Dr Inventory; Cr Deferred Tax Liability ( s t e p − u p × t step-up \times t s t e p − u p × t ); Cr BCV Reserve (after-tax step-up)
Identifiable Intangible Assets (e.g., Brand, Software) Recognized at FV (carrying value $0 in subsidiary) Taxable temporary difference ( C A > T B CA > TB C A > TB ) Dr Intangible Assets; Cr Deferred Tax Liability ( F V × t FV \times t F V × t ); Cr BCV Reserve (after-tax FV)
Contingent Liabilities Present obligation measurable at FV under IFRS 3.23 Deductible temporary difference ( C A > T B CA > TB C A > TB ) Dr BCV Reserve (after-tax obligation); Dr Deferred Tax Asset ( F V × t FV \times t F V × t ); Cr Provision / Contingent Liability (gross FV)
Exam Trap: Candidates often ask whether the initial recognition exemption under IAS 12.15(b) prevents recognizing deferred tax on these assets. Under IAS 12.15(b)(i) and 12.24(a), the initial recognition exemption does not apply to business combinations . Deferred taxes must be recognized on all identifiable assets and liabilities adjusted to fair value in a business combination.
Loading diagram... Consolidation Worksheet and Valuation Adjustment Sequence
Pre-Acquisition Equity Elimination Mechanics
The pre-acquisition elimination entry cancels the parent's asset Investment in Subsidiary against the subsidiary's pre-acquisition equity balances and the after-tax BCV reserve, while recognizing Goodwill (or Gain on Bargain Purchase) and the Non-Controlling Interest at the acquisition date.
The Standard Pre-Acquisition Elimination Entry Consolidation Journal Entry (Acquisition Date):
- Dr Share Capital (Subsidiary - pre-acquisition) [Book Value]
- Dr Retained Earnings (Subsidiary - pre-acquisition) [Book Value]
- Dr General Reserve (Subsidiary - pre-acquisition) [Book Value]
- Dr BCV Reserve (Total after-tax fair value adjustments) [After-Tax FV Step-ups]
- Dr Goodwill (Consolidated asset) [Calculated]
- Cr Investment in Subsidiary (Parent's asset) [Purchase Cost]
- Cr Non-Controlling Interest (NCI at acquisition date) [Proportionate or FV]
If the combination produces a gain on bargain purchase (where Identifiable Net Assets at Fair Value exceed Consideration + NCI), the credit is recognized immediately in profit or loss (in the period of acquisition) after a thorough reassessment of fair values.
Subsequent-Period Consolidation Entries: Amortization & Realization
In financial periods following the acquisition date, two critical accounting requirements arise:
Re-enacting the Past: Because consolidation entries are not recorded in the physical general ledgers of either company, the BCV entries and pre-acquisition elimination entries must be re-entered in every subsequent consolidation worksheet for as long as the parent holds the investment.
Accounting for Realization: As the underlying revalued assets are consumed, depreciated, or sold, their fair value step-ups must be recognized in consolidated profit or loss, and the related deferred taxes must be unwound.
1. Undervalued Inventory Sold Post-Acquisition
In Year of Sale (Year 1): When the undervalued inventory on hand at acquisition date is sold to external customers during Year 1, consolidated cost of goods sold must be increased to reflect the higher acquisition-date fair value:
- Dr Cost of Sales (P/L) [Gross Step-up]
- Cr Inventory (Balance Sheet) [Gross Step-up]
- Dr Deferred Tax Liability (Balance Sheet) [Gross Step-up × t \times t × t ]
- Cr Income Tax Expense (P/L) [Gross Step-up × t \times t × t ]
In Subsequent Periods (Year 2 and Beyond): In Year 2, because the inventory was sold in Year 1, the expense affected Year 1 profit. In Year 2, that expense now resides in opening retained earnings :
- Dr Retained Earnings (opening) [After-tax inventory step-up]
- Dr Deferred Tax Liability [Tax on step-up]
- Cr Inventory [Gross step-up] (clearing the original BCV inventory entry)
- 2. Fair Value Step-Up on Depreciable Plant & Equipment
If plant and equipment is stepped up by Δ F V \Delta FV Δ F V at acquisition with a remaining useful life of N N N years:
Annual Additional Depreciation: Annual Depreciation = Δ F V N \text{Annual Depreciation} = \frac{\Delta FV}{N} Annual Depreciation = N Δ F V
Annual Tax Unwinding: Annual Tax Reversal = Annual Depreciation × t \text{Annual Tax Reversal} = \text{Annual Depreciation} \times t Annual Tax Reversal = Annual Depreciation × t Consolidation Journal Entry — Year 1 (Current Period Adjustment):
- Dr Depreciation Expense (P/L) [ΔFV / N]
- Cr Accumulated Depreciation (Balance Sheet) [ΔFV / N]
- Dr Deferred Tax Liability (Balance Sheet) [(ΔFV / N) × t]
- Cr Income Tax Expense (P/L) [(ΔFV / N) × t]
In Year 2, the prior year's depreciation resides in opening retained earnings, while the current year's depreciation hits current profit or loss: Consolidation Journal Entry — Year 2 (Subsequent Period Adjustment):
- Dr Retained Earnings (opening) [Prior year depreciation] [ΔFV / N]
- Dr Depreciation Expense (P/L) [Current year depreciation] [ΔFV / N]
- Cr Accumulated Depreciation (Balance Sheet) [Cumulative 2 years] [2 × (ΔFV / N)]
- Dr Deferred Tax Liability (Balance Sheet) [Cumulative 2 years] [2 × (ΔFV / N) × t]
- Cr Retained Earnings (opening) [Prior year tax reversal] [(ΔFV / N) × t]
- Cr Income Tax Expense (P/L) [Current year tax reversal] [(ΔFV / N) × t]
- Comprehensive Worked Case Study: Acquisition Analysis and Multi-Year Consolidation
- Transaction Details
On 1 July 2024, Meridian Ltd acquires 80% of the ordinary shares of Terra Ltd for $520,000 cash . Meridian measures Non-Controlling Interest at its proportionate share of Terra's identifiable net assets. The statutory corporate tax rate is 30% .
At 1 July 2024, Terra Ltd's statement of financial position reflects:
- Ordinary Share Capital: $300,000
- Retained Earnings: $150,000
- Total Equity: $450,000
All identifiable assets and liabilities of Terra Ltd are recorded at fair value, with the following exceptions:
Land: Carrying value $100,000; Fair value $150,000 (Fair value step-up = $50,000).
Plant & Equipment: Carrying value $160,000; Fair value $200,000 (Fair value step-up = $40,000; remaining useful life = 5 years, straight-line).
Inventory: Carrying value $70,000; Fair value $90,000 (Fair value step-up = $20,000). All undervalued inventory is sold during FY2025 (year ended 30 June 2025).
Step 1: Acquisition Analysis Schedule (1 July 2024) Pre-Tax Fair Value Adjustments = $ 50 K (Land) + $ 40 K (Plant) + $ 20 K (Inventory) = $ 110 , 000 Deferred Tax Liability Recognized = $ 110 , 000 × 30 % = $ 33 , 000 After-Tax BCV Adjustments = $ 110 , 000 − $ 33 , 000 = $ 77 , 000 Identifiable Net Assets at FV = $ 450 , 000 (Book Equity) + $ 77 , 000 = $527,000 \begin{aligned}
\text{Pre-Tax Fair Value Adjustments} &= \$50\text{K (Land)} + \$40\text{K (Plant)} + \$20\text{K (Inventory)} = \$110,000 \\[4pt]
- \text{Deferred Tax Liability Recognized} &= \$110,000 \times 30\% = \$33,000 \\[4pt]
- \text{After-Tax BCV Adjustments} &= \$110,000 - \$33,000 = \$77,000 \\[4pt]
- \text{Identifiable Net Assets at FV} &= \$450,000 \text{ (Book Equity)} + \$77,000 = \textbf{\$527,000}
\end{aligned} Pre-Tax Fair Value Adjustments Deferred Tax Liability Recognized After-Tax BCV Adjustments Identifiable Net Assets at FV = $50 K (Land) + $40 K (Plant) + $20 K (Inventory) = $110 , 000 = $110 , 000 × 30% = $33 , 000 = $110 , 000 − $33 , 000 = $77 , 000 = $450 , 000 (Book Equity) + $77 , 000 = $527,000
- Component Valuation Amount
- Consideration Transferred (80%) $520,000
- Non-Controlling Interest (20% of $527,000) $105,400
- Total Combined Consideration & NCI $625,400
- Less: Identifiable Net Assets at Fair Value ($527,000)
- Goodwill Recognized at Acquisition $98,400
Step 2: Consolidation Entries at Acquisition Date (1 July 2024) Entry 1: Business Combination Valuation (BCV) Entry
- Dr Land $50,000
- Dr Plant & Equipment $40,000
- Dr Inventory $20,000
- Cr Deferred Tax Liability ($110,000 × 30%) $33,000
- Cr BCV Reserve ($110,000 × 70%) $77,000
- Entry 2: Pre-Acquisition Equity Elimination Entry
- Dr Share Capital $300,000
- Dr Retained Earnings $150,000
- Dr BCV Reserve $77,000
- Dr Goodwill $98,400
- Cr Investment in Terra Ltd $520,000
- Cr Non-Controlling Interest ($527,000 × 20%) $105,400
- Step 3: Consolidation Entries at Year 1 End (30 June 2025)
In the first year post-acquisition, the undervalued inventory is sold, and the plant is depreciated by one year ($40,000 / 5 = $8,000): Re-enter BCV and Pre-Acquisition Elimination Entries (Entries 1 & 2 above).
- Entry 3: Realization of Undervalued Inventory Sold in Year 1
- Dr Cost of Sales (P/L) $20,000
- Cr Inventory $20,000
- Dr Deferred Tax Liability ($20,000 × 30%) $6,000
- Cr Income Tax Expense (P/L) $6,000
- Entry 4: Additional Depreciation on Plant Step-Up (Year 1)
- Dr Depreciation Expense ($40,000 / 5 years) $8,000
- Cr Accumulated Depreciation $8,000
- Dr Deferred Tax Liability ($8,000 × 30%) $2,400
- Cr Income Tax Expense (P/L) $2,400
- Step 4: Consolidation Entries at Year 2 End (30 June 2026)
In Year 2, the prior year's realization adjustments hit opening retained earnings, while Year 2 incurs another $8,000 of plant depreciation: Re-enter BCV and Pre-Acquisition Elimination Entries (Entries 1 & 2 above).
- Entry 5: Prior Year Inventory Realization (Rolled into Opening Retained Earnings)
- Dr Retained Earnings (opening) ($20,000 × 70%) $14,000
- Dr Deferred Tax Liability $6,000
- Cr Inventory $20,000
- Entry 6: Plant Depreciation Adjustments (Cumulative Years 1 & 2)
- Dr Retained Earnings (opening) [Year 1 depreciation] $8,000
- Dr Depreciation Expense (P/L) [Year 2 current depreciation] $8,000
- Cr Accumulated Depreciation [2 years cumulative: $8,000 × 2] $16,000
- Dr Deferred Tax Liability [2 years cumulative: $16,000 × 30%] $4,800
- Cr Retained Earnings (opening) [Year 1 tax benefit] $2,400
- Cr Income Tax Expense (P/L) [Year 2 tax benefit] $2,400
The net effect on opening retained earnings is $5,600 ($8,000 Year 1 depreciation less $2,400 Year 1 tax benefit), and the entry balances: debits $20,800 = credits $20,800.
Step 5: Non-Controlling Interest After Acquisition
Because Meridian measured NCI at its proportionate share of identifiable net assets, NCI is entitled to 20% of Terra's post-acquisition equity movements, adjusted for the BCV entries (which form part of Terra's net assets in the group). Assume Terra reports a profit after tax of $90,000 for FY2025 and pays a dividend of $20,000 in June 2025.
- NCI calculation (FY2025) Amount
- Terra's reported profit after tax $90,000
- Less: inventory step-up realised, after tax ($20,000 × 70%) ($14,000)
- Less: additional plant depreciation, after tax ($8,000 × 70%) ($5,600)
- Adjusted profit for NCI $70,400
- NCI share of profit (20%) $14,080 Entry 7: NCI Share of Current-Year Profit (FY2025)
- Dr NCI Share of Profit (attribution in P/L) $14,080
- Cr Non-Controlling Interest (equity) $14,080
- Entry 8: NCI Share of Dividend Paid (FY2025)
- Dr Non-Controlling Interest (equity) $4,000
- Cr Dividend Paid (Terra) $4,000
NCI at 30 June 2025 = $105,400 (acquisition date) + $14,080 − $4,000 = $115,480 . The parent's 80% share of the dividend ($16,000) is eliminated against Meridian's dividend revenue (Section 10.3).
In FY2026, the FY2025 movements sit in opening retained earnings. NCI's share of Terra's adjusted post-acquisition retained earnings at 1 July 2025 is 20% × ($90,000 − $20,000 − $14,000 − $5,600) = 20% × $50,400 = $10,080 : Entry 9: NCI Share of Opening Post-Acquisition Retained Earnings (FY2026)
- Dr Retained Earnings (opening) $10,080
- Cr Non-Controlling Interest (equity) $10,080
Together with Entry 2 ($105,400), this restores the opening NCI of $115,480. NCI's share of FY2026 profit and dividends is then added using Entries 7 and 8. When there are upstream intragroup sales, the unrealised profit also reduces the subsidiary profit used for NCI (Section 10.4).